SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?


To: y2kfree_radical who wrote (66435)10/6/2000 4:02:23 AM
From: LANCE B  Read Replies (2) | Respond to of 150070
 
ORCH AND DNAP-THE START OF A BEAUTIFUL RELATIONSHIP

PRINCETON, N.J., and SARASOTA, FL., Oct. 6, 2000 – Orchid BioSciences, Inc. (Nasdaq: ORCH) and DNAPrint genomics, Inc, today announced that DNAPrint has agreed to purchase Orchid’s SNPstream™ 25K system for industrial-scale single nucleotide polymorphism (SNP) scoring. DNAPrint researchers will conduct high throughput genotyping using Orchid’s SNPstream 25K platform and SNPware™ kits incorporating the company’s proprietary SNP-IT™ primer extension biochemistries and software. Under terms of the agreement, DNAPrint will make an upfront payment to Orchid and will purchase SNPware consumables on a per unit basis. Other details of the agreement were not disclosed.



To: y2kfree_radical who wrote (66435)10/9/2000 5:24:24 PM
From: thescot  Respond to of 150070
 
y2kfree_radical
no question about it.
they should not be expected to be profitable for some time nor does the market assume they will be, they are a startup co after all.
cheers
david